536 related articles for article (PubMed ID: 28501926)
1. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
[TBL] [Abstract][Full Text] [Related]
2. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.
Cornely OA; Vehreschild MJGT; Adomakoh N; Georgopali A; Karas A; Kazeem G; Guery B
Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1187-1194. PubMed ID: 30911926
[TBL] [Abstract][Full Text] [Related]
3. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
[TBL] [Abstract][Full Text] [Related]
4. Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection.
Chen Y; Rashid MU; Huang H; Fang H; Nord CE; Wang M; Weintraub A
J Microbiol Immunol Infect; 2017 Aug; 50(4):532-536. PubMed ID: 26698688
[TBL] [Abstract][Full Text] [Related]
5. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
Gómez S; Chaves F; Orellana MA
Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
[TBL] [Abstract][Full Text] [Related]
6. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR
J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China.
Zhou Y; Mao L; Yu J; Lin Q; Luo Y; Zhu X; Sun Z
BMC Infect Dis; 2019 Mar; 19(1):232. PubMed ID: 30845918
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of Clostridium difficile infection.
Dupont HL
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
[TBL] [Abstract][Full Text] [Related]
11. Impact of Clostridium difficile infection caused by the NAP1/RT027 strain on severity and recurrence during an outbreak and transition to endemicity in a Mexican tertiary care center.
Tamez-Torres KM; Torres-González P; Leal-Vega F; García-Alderete A; López García NI; Mendoza-Aguilar R; Galindo-Fraga A; Bobadilla-Del Valle M; Ponce de León A; Sifuentes-Osornio J
Int J Infect Dis; 2017 Dec; 65():44-49. PubMed ID: 28986313
[TBL] [Abstract][Full Text] [Related]
12. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.
van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ
J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013
[TBL] [Abstract][Full Text] [Related]
14. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
Thabit AK; Housman ST; Burnham CD; Nicolau DP
J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
[TBL] [Abstract][Full Text] [Related]
15. Secular trends in the epidemiology of Clostridium difficile infection (CDI) at a tertiary care hospital in Barcelona, 2006-2015: A prospective observational study.
Larrainzar-Coghen T; Rodríguez-Pardo D; Fernández-Hidalgo N; Puig-Asensio M; Pigrau C; Ferrer C; Rodríguez V; Bartolomé R; Campany D; Almirante B
Anaerobe; 2018 Jun; 51():54-60. PubMed ID: 29655966
[TBL] [Abstract][Full Text] [Related]
16. Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS
Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile recurrences in Stockholm.
Sandell S; Rashid MU; Jorup-Rönström C; Ellström K; Nord CE; Weintraub A
Anaerobe; 2016 Apr; 38():97-102. PubMed ID: 26802875
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.
Russo A; Falcone M; Fantoni M; Murri R; Masucci L; Carfagna P; Ghezzi MC; Posteraro B; Sanguinetti M; Venditti M
Clin Microbiol Infect; 2015 May; 21(5):493.e1-4. PubMed ID: 25698658
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study.
Haubitz S; Bartlomé N; Bucheli Laffer E; Spelters C; Fankhauser H; Fux CA
Swiss Med Wkly; 2020 Jan; 150():w20173. PubMed ID: 31940431
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain.
Reigadas E; Alcalá L; Marín M; Pelaéz T; Martin A; Iglesias C; Bouza E
J Antimicrob Chemother; 2015 Aug; 70(8):2311-5. PubMed ID: 25876881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]